SINTX Technologies Hits New 52-Week Low at $1.96 Amid Ongoing Struggles

SINTX Technologies, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 1.96 as of June 2, 2026. This decline reflects a significant downturn, with the stock's performance over the past year showing a decrease of 54.29%, starkly contrasting with the S&P 500's gain of 28.2% during the same period. The company's financial metrics indicate ongoing challenges, including a negative return on equity of -234.73% and a debt-to-equity ratio of -1.43. SINTX has reported losses for five consecutive quarters, with net sales for the half-year at USD 0.67 million, down 26.45%. The return on capital employed (ROCE) stands at a notably low -311.41%, and the inventory turnover ratio is just 1.29 times. Additionally, institutional investor participation has waned, with a 1.89% decrease in stakes over the last quarter, leaving them with a collective holding of 11.43%. These factors contribute to a challenging market position for SINTX Technologies, as it navigates a difficult financial landscape.